Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment.
Duchenne muscular dystrophy (DMD) is caused by mutations in the gene that encodes the 427-kDa cytoskeletal protein dystrophin. Increased knowledge of the function of dystrophin and its role in muscle has led to a greater understanding of the pathogenesis of DMD. This, together with advances in the g...
Auteurs principaux: | Nowak, K, Davies, K |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2004
|
Documents similaires
-
Dystrophin hydrophobic regions in the pathogenesis of Duchenne and Becker muscular dystrophies
par: Yingyin Liang, et autres
Publié: (2015-05-01) -
The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
par: Guiraud, S, et autres
Publié: (2019) -
Micro-dystrophin genes bring hope of an effective therapy for duchenne muscular dystrophy
par: Davies, K, et autres
Publié: (2019) -
Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular Dystrophy
par: Cedric Happi Mbakam, et autres
Publié: (2022-03-01) -
Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy.
par: Griffin, J, et autres
Publié: (2002)